Post Approval Requirements for Drugs: An Introduction to Safety Reporting and Post-Approval Changes

Quantity

Back to Results

Recorded April 21, 2021 | On-Demand Webinar

Discuss pharmacovigilance and Adverse Drug Experience (ADE) Reporting. Explore FDA’s drug safety review activities. Review Medicare, Medicaid, and reimbursement issues. Learn about the Drug Supply Chain Security Act (DSCSA) product tracing requirements.

This session was recorded as part of FDLI’s virtual Introduction to Drug Law and Regulation course in April 2021.

Assign Members :

Members Assigned | Assign all contacts Unassign all contacts

Add New Contact

Assign	Full Name	Account Name	Email	Role

Total Records - Showing Page

Add New Contact

Discounts and special pricing for additional items will be applied once you add the item to your cart.